Kissei Pharmaceutical Co., Ltd.
Total Valuation
USDAs of March 31, 2026, Kissei Pharmaceutical Co., Ltd. carries a market capitalization of 1.08B, placing it among publicly traded companies globally. Its enterprise value stands at 748.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.08B |
| Enterprise Value | 748.86M |
Important Dates
Kissei Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 4, 2026.
| Earnings Date | 11/4/2026 |
Share Statistics
As of March 31, 2026, Kissei Pharmaceutical Co., Ltd. has 41.45M shares outstanding.
| Shares Outstanding | 41.45M |
Valuation Ratios
These figures are as of March 31, 2026.
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.75 |
Financial Position
As of March 31, 2026, Kissei Pharmaceutical Co., Ltd. maintains a current ratio of 5.30, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.30 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.54 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 1,780.00 |
Stock Price Statistics
USDAs of the close on October 1, 2026, Kissei Pharmaceutical Co., Ltd.'s stock has declined approximately 19.09% over the past 52 weeks.
| 52-Week Price Change | -19.09% |
| 50-Day Moving Average | 21.30 |
Balance Sheet
USDAs of March 31, 2026, Kissei Pharmaceutical Co., Ltd. holds 342.97M in cash and equivalents against 7.88M in total debt, resulting in a net debt position of -175.24M. Total book value stands at 1.45B, with working capital of 587.84M providing operational flexibility.
| Cash & Cash Equivalents | 342.97M |
| Total Debt | 7.88M |
| Net Debt | -175.24M |
| Equity (Book Value) | 1.45B |
| Book Value Per Share | 34.99 |
| Working Capital | 587.84M |
Stock Splits
Kissei Pharmaceutical Co., Ltd.'s most recent stock split took place on March 26, 1996 with a 10:11 split ratio.
| Last Split Date | 3/26/1996 |
| Split Ratio | 10:11 |